12 Health Care Stocks Moving In Thursday's Intraday Session
GainersMolecular Partners (NASDAQ:MOLN) stock rose 39.1% to $11.07 during Thursday's regular session. The market value of their outstanding shares is at $367.3 million. Zentalis Pharma (NASDAQ:ZNTL) s
BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO
BioSig Technologies (BSGM) said Monday it has appointed Ferdinand Groenewald as interim chief financial officer. Groenewald is currently the vice president of finance at Alaunos Therapeutics (TCRT), B
Alaunos Therapeutics (TCRT.US): The 2024 Q1 financial report achieved revenue of $1,000, previous value of $0; earnings per share of -0.11 dollars, previous value of -0.63 dollars.
Alaunos Therapeutics (TCRT.US): The 2024 Q1 financial report achieved revenue of $1,000, previous value of $0; earnings per share of -0.11 dollars, previous value of -0.63 dollars.
Alaunos Therapeutics | 10-Q: Quarterly report
Alaunos Therapeutics Announces Executive Financial Leadership Changes
Alaunos Therapeutics Regains Nasdaq Listing Compliance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersCogent Biosciences (NASDAQ:COGT) shares rose 45.6% to $7.95 during Wednesday's pre-market session. The company's market cap stands at $684.6 million. Lineage Cell Therapeutics (AMEX:LCTX) stock
TCRT, NXT and MINM Among Mid-day Movers
Alaunos Therapeutics To Carry Out 1-for-15 Reverse Stock Split On February 1st, 2024
January 30th - $Alaunos Therapeutics(TCRT.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from February 1st, 2024.$Alaunos
Alaunos Therapeutics Appoints Dale Curtis Hogue As Interim CEO, Effective Jan. 20 2024; Hogue Will Continue Serving On The Board
Alaunos Therapeutics Appoints Dale Curtis Hogue As Interim CEO, Effective Jan. 20 2024; Hogue Will Continue Serving On The Board
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersMesoblast (NASDAQ:MESO) shares increased by 22.1% to $2.1 during Friday's pre-market session. The company's market cap stands at $180.2 million. Sangamo Therapeutics (NASDAQ:SGMO) stock rose 20
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAkso Health Group (NASDAQ:AHG) stock increased by 23.4% to $1.32 during Monday's after-market session. The market value of their outstanding shares is at $30.1 million. Assure Hldgs (NASDAQ:ION
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAinos (NASDAQ:AIMD) stock moved upwards by 74.0% to $3.01 during Friday's regular session. The market value of their outstanding shares is at $14.0 million. Elevation Oncology (NASDAQ:ELEV) sto
On December 22, 2023, Alaunos Therapeutics Entered Into Separation And Release Agreement With CEO Kevin Boyle In Connection With Boyle's Termination - Filing
The Company and Boyle also entered into a consulting agreement, effective January 1, 2024, pursuant to which Boyle will continue providing strategic and advisory services to the company. The Consultin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersBiomerica (NASDAQ:BMRA) shares rose 54.5% to $1.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $25.7 million. Cingulate (NASDAQ:CING) stock increased
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersBiomerica (NASDAQ:BMRA) shares rose 71.7% to $1.7 during Monday's pre-market session. The market value of their outstanding shares is at $28.5 million. Arcutis Biotherapeutics (NASDAQ:ARQT) sha
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMira Pharmaceuticals (NASDAQ:MIRA) shares moved upwards by 9.2% to $3.59 during Friday's after-market session. The market value of their outstanding shares is at $53.0 million. TC BioPharm (Hol
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersPaxMedica (NASDAQ:PXMD) shares rose 33.6% to $1.07 during Wednesday's regular session. The market value of their outstanding shares is at $1.1 million. Impel Pharmaceuticals (NASDAQ:IMPL) share
Recap: Alaunos Therapeutics Q3 Earnings
Alaunos Therapeutics (NASDAQ:TCRT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:30 AM.Here's what investors need to know about the announcement.EarningsAlaunos Therapeutics mis
Alaunos Therapeutics Q3 EPS $(0.04), Same As Last Year
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share. This is unchanged from the same period last year.